Skip to main content

Table 4 The differences in MRS metabolites between patient groups at 2 nd MRS assessment

From: The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type

  

Disease

SCA3*

SCA6*

MSA-C*

Cerebellar hemispheres

NAA/Cr

SCA2

0.001

0.014

0.017

  

SCA3

-

0.538

0.000

  

SCA6

-

-

0.022

 

Cho/Cr

SCA2

0.197

0.393

0.055

  

SCA3

-

0.979

0.001

  

SCA6

-

-

0.067

 

NAA/Cho

SCA2

0.026

0.089

0.617

  

SCA3

-

0.456

0.077

  

SCA6

-

-

0.202

Vermis

NAA/Cr

SCA2

0.064

0.355

0.356

  

SCA3

-

0.526

0.000

  

SCA6

-

-

0.085

 

Cho/Cr

SCA2

0.017

0.064

0.480

  

SCA3

-

0.880

0.003

  

SCA6

-

-

0.133

 

NAA/Cho

SCA2

0.484

0.165

0.777

  

SCA3

-

0.233

0.202

  

SCA6

-

-

0.390

  1. SCA2: Spinocerebellar ataxia type 2; SCA3: Spinocerebellar ataxia type 3; SCA6: Spinocerebellar ataxia type 6; MSA-C: Multiple system atrophy-cerebellar type.
  2. *Mann–Whitney test, p value.